24/7 Market News Snapshot 14 July, 2025 – 60 Degrees Pharmaceuticals, Inc. Common Stock (NASDAQ:SXTP)

July 14, 2025

DENVER, Colo., 14 July, 2025 (www.247marketnews.com) – (NASDAQ:SXTP) are discussed in this article.
60 Degrees Pharmaceuticals, Inc. is experiencing a notable surge in its market performance, with shares opening at $2.52 and currently trading at $2.713, reflecting a robust increase of 7.66%. This positive momentum is underscored by a trading volume of 2.02 million, indicating strong investor interest. Analysts may consider examining technical indicators such as moving averages and support/resistance levels to better gauge short-term trends. Given that the stock price remains above its opening level, continued bullish sentiment could make it an appealing option for traders.

In parallel, the Company has announced significant advancements in its tafenoquine drug, branded as ARAKODA®, aimed at treating acute canine babesiosis. Promising results from three clinical efficacy studies highlight the drug’s potential in correcting this serious infection in dogs, which affects several hundred to thousands of canines annually. Existing treatments often face issues like toxicity and resistance, making this new development particularly important. The administered tablet form of tafenoquine demonstrated favorable tolerability in canine subjects, aiding their recovery from Babesia infections.

Looking forward, 60 Degrees Pharmaceuticals plans to submit an application for a Minor Use Minor Species (MUMS) designation to the FDA, based on a comprehensive analysis of both new efficacy data and previously established safety protocols related to the drug’s original development for malaria. CEO Geoff Dow expressed enthusiasm about these findings, noting their significance in both veterinary and human healthcare. As the Company continues to innovate within the infectious disease sector, it aims to expand its therapeutic horizons, making strides in improving health outcomes for both humans and pets alike.

Related news for (SXTP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.